Because overexpression of HOXA9 rescued the defects of leukemia growth after RBM5 loss, we speculate that the noncanonical transcriptional regulation of HOXA9 by RBM5 is one of the primary mechanisms in AML. This evidence concerns the gene HOXA9 and leukemia.